Apixaban on Patients With AFib, VHD Had Better Results Than Rivaroxaban, Study Reveals

Medicine & Technology Oct 19, 2022

Researchers compared the efficacy and safety of apixaban and rivaroxaban in treating atrial fibrillation and valvular heart disease (VHD). Read the article to know the more on the results of their study.

New Anticoagulant Can Inactivate Blood Clotting Enzyme Thrombin

Jul 15, 2022

A team of researchers discover a biomolecular anticoagulant platform that can inactivate a blood clotting enzyme. Continue reading to learn more about the new anticoagulant and its future use in the field of medicine.

Comprehensive Study Shows Transparent Outcomes of Postprocedure Drugs Related to First-Generation Watchman Operations

May 04, 2022

A series of papers recently released showed a comprehensive outcome from widescale trials and procedures related to first-generation Watchman device. Read more about the effects of these operations, as well as the impact of postprocedure medications.

Common Blood Thinning Drug Heparin Improves COVID-19 Symptoms, Increase Oxygen Levels by 70%

Jan 21, 2022

Researchers found that the anticoagulant heparin could help treat COVID-19 patients as it improves symptoms and increase oxygen levels in the lungs by about 70%.

FDA-Approved Blood Thinner Heparin Found to Neutralize SARS-CoV-2 Virus

Jul 15, 2020

A new study reveals that heparin, a common blood thinner, could play an important role in controlling COVID-19. Scientists are optimistic as the same approach has been used in other viruses such as dengue and Zika.